Physician profile
Marcio Fagundes
NPI 1063604692
$273,886.67
in general payments reported to CMS, 2019-2025
10 companies · $34K in 2025
The $34K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $38K · 2021: $40K · 2022: $84K · 2023: $39K · 2024: $9,130 · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $3,583 · Food and Beverage: $2,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,768.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,687.50 |
| Travel and Lodging | $3,582.95 |
| Food and Beverage | $2,663.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $235,122.42 | 2019-2025 | Spaceoar System, Spaceoar Vue System - 10ml, General - Therapies |
| Augmenix, INC. | $20,872.60 | 2019 | |
| Palette Life Sciences, INC. | $13,275.84 | 2023 | |
| Bioprotect Medical, INC. | $1,798.28 | 2024-2025 | Bioprotect Balloon Implant System |
| Ion Beam Applications S.A. | $1,343.00 | 2019-2020 | |
| Qfix | $1,000.00 | 2019 | |
| Pfizer INC. | $277.26 | 2023-2025 | |
| Iba Proton Therapy, INC. | $107.63 | 2023 | |
| Siemens Medical Solutions USA, INC. | $63.65 | 2021 | |
| Accuray Incorporated | $25.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcio Fagundes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.